Kalbe Farma Tbk vs Kokoh Exa Nusantara Tbk — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Kokoh Exa Nusantara Tbk trades at Rp101 (market cap 451.21B, 14.06M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 73.1× Kokoh Exa Nusantara Tbk's market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 14.06M). Which is the better fit depends on your goals.
| KLBF | KOCI | |
|---|---|---|
Market Cap | 33T | 451.21B |
Volume | 98.44M | 14.06M |
Lot | 984.38K | 140.63K |
Turnover | 70.64B | 1.41B |
Average Price | 717.58 | 100.56 |
Value | 70.64B | 1.41B |
Indicative Equilibrium Price | 720 | 101 |
Indicative Equilibrium Volume | 43.62K | 1.94K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI →